- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
GU Cancers Symposium 2012 - Active surveillance vs. watchful waiting for localized prostate cancer
February 15, 2012
Nerve mapping for prostatectomies: Novel technologies under development - Abstract
February 14, 2012
Inhibitors of androgen and estrogen biosynthesis in castration-resistant prostate cancer - Abstract
February 13, 2012
Clinical efficacy of TroVax in the treatment of progressive castration-resistant prostate cancer - Abstract
February 10, 2012
Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia - Abstract
February 10, 2012
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review - Abstract
February 10, 2012
Does antibiotherapy prevent unnecessary prostate biopsies in patients with high PSA values? - Abstract
February 10, 2012
The emerging role of diffusion-weighted MRI in prostate cancer management - Abstract
February 9, 2012
Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients - Abstract
February 9, 2012
Androgen deprivation therapy in prostate cancer: Focusing on sexual side effects - Abstract
February 9, 2012
Seven years of experience with high-intensity focused ultrasound for prostate cancer: Advantages and limitations - Abstract
February 9, 2012
Distinct redox profiles of selected human prostate carcinoma cell lines: Implications for rational design of redox therapy - Abstract
February 8, 2012
Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era - Abstract
February 8, 2012